Mirum Pharmaceuticals, Inc. (MIRM) Financials

MIRM Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.0 billion 1.1 billion
March 31, 2026 890.9 million 648.4 million
Dec. 31, 2025 842.8 million 528.1 million
Sept. 30, 2025 785.1 million 493.1 million

MIRM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -273.7 million 66.8 million
March 31, 2026 -229.4 million 36.2 million
Dec. 31, 2025 5.5 million 19.0 million
Sept. 30, 2025 39.5 million 18.1 million

MIRM Net Income

No data available :(

MIRM Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 438.3 million 750.1 million 10.5 million
March 31, 2026 386.3 million 310.3 million 13.5 million
Dec. 31, 2025 383.3 million 309.8 million 9.7 million
Sept. 30, 2025 375.5 million 309.4 million 9.4 million

MIRM Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 63.4 million
March 31, 2026 58.9 million
Dec. 31, 2025 50.2 million
Sept. 30, 2025 57.0 million

MIRM Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 687000 90.5 million 81.5 million -
March 31, 2026 664000 97.9 million 96.3 million -
Dec. 31, 2025 600000 51.1 million 74.1 million -
Sept. 30, 2025 187000 43.0 million 61.9 million -

MIRM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 176.2 million 30.3 million
March 31, 2026 159.9 million 28.9 million
Dec. 31, 2025 148.9 million 28.3 million
Sept. 30, 2025 133.0 million 25.5 million

MIRM Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MIRM

Price: $100.64

52 week price:
57.79
130.00

Earnings Per Share: -13.81 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 266732

Market Capitalization: 6.0 billion

Links: